SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
onlywei
Lv1
20 积分
2023-05-31 加入
最近求助
最近应助
互助留言
HDM-2 inhibition suppresses expression of ribonucleotide reductase subunit M2, and synergistically enhances gemcitabine-induced cytotoxicity in mantle cell lymphoma
3天前
已完结
Mdm2 inhibitors synergize with topoisomerase II inhibitors to induce p53‐independent pancreatic cancer cell death
3天前
已完结
First-line Chemotherapy in Advanced Biliary Tract Cancer Ten Years After the ABC-02 Trial: “And Yet It Moves!”
6天前
已完结
Combination Therapies for Advanced Biliary Tract Cancer
6天前
已完结
Rational development of combination therapies for biliary tract cancers
6天前
已完结
First-line chemotherapy plus immunotherapy in biliary tract cancer
15天前
已完结
Ponatinib for the treatment of adult patients with resistant or intolerant Chronic-Phase Chronic Myeloid Leukemia
18天前
已完结
Management of Chronic Myeloid Leukemia Patients in Later Lines: The Role of Ponatinib and New Compounds
18天前
已完结
UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia
30天前
已完结
Treatment of Adults With Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia—From Intensive Chemotherapy Combinations to Chemotherapy-Free Regimens
30天前
已完结
没有进行任何应助
就是这篇,感谢感谢
1个月前
就是这篇,感谢感谢
1个月前
太感谢了,Have a nice day!
3个月前
太感谢了
3个月前
非常感谢
9个月前
感谢,帮大忙了
10个月前
感谢
10个月前
非常感谢
10个月前
非常感谢~~~~
10个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论